a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture

NCT07502651 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Sedation

Interventions

DRUG: Midazolam (Intranasal)
DRUG: Dexmedetomidine (Intranasal)

Sponsor

Postgraduate Institute of Dental Sciences Rohtak